Journals / JAREM / 2020 / Cilt: 10 - Sayı: 1

The Effect of Smoking on Serum Nesfatin-1 Levels on Women Who are in Follicular Phase: A Pilot Study

Sigara İçmenin Foliküler Fazdaki Kadınlarda Serum Nesfatin-1 Değerleri Üzerindeki Etkisi: Bir Pilot Çalışma

Journal
JAREM
Pages
23–26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The levels of serum nesfatin-1 was found significantly lower in female smokers than the non-smokers in early follicular phase.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Nesfatin-1, derived from NEFA/nucleobindin 2, is a hormone that suppresses food intake via melanocortin system in hypothalamus and has role on ovarian development.
📊
Key Findings & Data:In this study, we aimed to determine the effect of smoking on serum nesfatin-1 levels on women who were in early follicular phase.
💡
Conclusion & Impact:Conclusion: The levels of serum nesfatin-1 was found significantly lower in female smokers than the non-smokers in early follicular phase.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Nesfatin-1, derived from NEFA/nucleobindin 2, is a hormone that suppresses food intake via melanocortin system in hypothalamus and has role on ovarian development. In this study, we aimed to determine the effect of smoking on serum nesfatin-1 levels on women who were in early follicular phase. Methods: This study included 32 female participants, as smokers (n=11) and non-smokers (n=21). Nesfatin-1, fasting blood glucose, low density lipoprotein (LDL), high density lipoprotein (HDL), total cholesterol and tryglicerides, follicule stimulating hormone (FSH), luteinizing hormone (LH), antimüllerian hormone (AMH) and estradiol levels were measured from the blood samples in early follicular phase and they were compared. Results: 34,3% (n=11) of participants were smokers and according to the Fagerström Nicotine Dependence Scale whose nicotine dependence levels were >7 while 65.6% (n=21) were non-smokers. Serum nesfatin-1 levels in smokers were (81±0.1 pg/mL) found significantly lower than non-smokers (125±0.1 pg/mL) (p=0.007). No significant differences were found between these two groups about the levels of fasting blood glucose, LDL, HDL, total cholesterol, triglycerides, FSH, LH, AMH and estradiol. Conclusion: The levels of serum nesfatin-1 was found significantly lower in female smokers than the non-smokers in early follicular phase.

Özet

Amaç: NEFA/nükleobindin 2’den kaynaklanan nesfatin-1, hipotalamusta melanokortin yoluyla yemek alımını baskılayan ve over gelişiminde görev alan bir hormondur. Bu çalışmada sigara içmenin, erken foliküler fazdaki kadınlarda serum nesfatin-1 değerleri üzerindeki etkisini belirlemeyi amaçladık. Yöntemler: Bu çalışmaya sigara içen (n=11) ve sigara içmeyen (n=21) olmak üzere 32 kadın dahil edildi. Erken foliküler fazda alınan kan örneklerinden nesfatin-1, açlık kan şekeri, düşük yoğunluklu lipoprotein (LDL), yüksek yoğunluklu lipoprotein (HDL), total kolesterol, trigliserid, folikül stimülan hormon (FSH), luteinizan hormon (LH), anti-mülleriyan hormon (AMH) ve estradiyol seviyeleri ölçüldü ve karşılaştırıldı. Bulgular: Katılımcıların %34,3’ü (n=11) sigara içen ve nikotin bağımlılığı seviyesi Fagerström Nikotin Bağımlılık Ölçeği’ne göre >7 olanlar olup, %65,62si (n=21) sigara içmeyen kadınlardı. Serum nesfatin-1 seviyeleri sigara içenlerde (81±0,1 pg/mL) sigara içmeyenlere göre (125±0,1 pg/mL) anlamlı olarak düşük bulundu (p=0,007). Bu iki grup arasında açlık kan şekeri, LDL, HDL, total kolesterol, trigliserid, FSH, LH, AMH ve estradiyol seviyeleri açısından anlamlı fark saptanmadı. Sonuç: Sigara içen kadınlarda sigara içmeyen kadınlara göre erken foliküler fazda ölçülen serum nesfatin-1 değerleri anlamlı olarak düşük bulunmuştur (p=0,007).

🔖

Cite This Article

YILDIZ, D. E., AKÇIĞ, Z., SALMAN, S., UÇAR, E., KARAMAN, S. T. (2020). The Effect of Smoking on Serum Nesfatin-1 Levels on Women Who are in Follicular Phase: A Pilot Study. JAREM, Cilt: 10 - Sayı: 1, 23–26. https://ajindex.com/articles/165137

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus.Nature. 2006; 443: 709-12
  2. Alp E, Görmüş U, Güdücü N, Bozkurt S. Nesfatin-1 levels and metabolic markers in polycystic ovary syndrome. Gynecol Endocrinol 2015;31: 543-7
  3. Kim J, Yang H. Nesfatin-1 as a new potent regulator in reproductive system. Dev Reprod 2012; 16: 253-64
  4. Stengel, A, Goebel M, Wang L, Rivier J, Kobelt P, Monnikes H, et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009; 150, 4911-9
  5. Li Z, Gao L, Tang H, Yin Y, Xiang X, Li Y, et al. Peripheral effects of nesfatin-1 on glucose homeostasis. PLoS One 2013; 8: e71513
  6. Yin Y, Li Z, Gao L, Li Y, Zhao J, Zhang W. AMPK-dependent modulation of hepatic lipid metabolism by nesfatin-1. Mol Cell Endocrinol 2015; 417: 20-6
  7. Garcés MF, Poveda NE, Sanchez E, Sánchez ÁY, Bravo SB, Vázquez MJ, et al. Regulation of NucB2/Nesfatin-1 throughout rat pregnancy. Physiol Behav 2014; 133: 216-22
  8. Çatlı G, Olgaç Dündar N, Dündar BN. Adipokines in breast milk: an update. J Clin Res Pediatr Endocrinol 2014; 6: 192-201
  9. Şengül Ö, Dilbaz B, Halıcı Z, Ferah I, Çadırcı E, Yılmaz F. Decreased serum nesfatin-1 levels in endometriosis. Eur J Obstet Gynecol Reprod Biol 2014; 177: 34-7
  10. Carranza-Lira S, Romero-Cuadra IA. Frequency of presentation and characteristics of chronic pelvic pain at the gynecologic consultation. Rev Med Inst Mex Seguro Soc 2018; 56: 226-30
  11. Ademoglu EN, Gorar S, Carlıoglu A, Yazıcı H, Dellal FD, Berberoglu Z, et al. Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome. J Endocrinol Invest 2014; 37: 715-9
  12. Ramesh N, Gawli K, Pasupulleti VK, Unniappan S. Metabolic and cardiovascular actions of nesfatin-1: implications in health and disease. Curr Pharm Des 2017; 23: 1453-64
  13. Pałasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz R, et al. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides. 2012; 46: 105-12
  14. Shen P, Han Y, Cai B, Wang Y. Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome. Sleep Breath 2015; 19: 515-22
  15. Algul S, Ozcelik O. Evaluating the levels of nesfatin-1 and ghrelin hormones in patients with moderate and severe major depressive disorders. Psychiatry Investig 2018; 15: 214-8